Bulbous corpuscle
Bulbous corpuscle
The Bulbous corpuscle or Ruffini ending is a type of mechanoreceptor found in the skin and subcutaneous tissue. These receptors are responsible for the sensation of continuous pressure and skin distortion. They are named after the Italian histologist Angelo Ruffini.
Etymology[edit | edit source]
The term "bulbous corpuscle" is derived from the Latin word "bulbus" meaning "bulb" and the Latin word "corpusculum" meaning "little body". The term "Ruffini ending" is named after Angelo Ruffini, an Italian histologist who first described these structures in 1898.
Structure and Function[edit | edit source]
Bulbous corpuscles are elongated, spindle-shaped receptors that are encapsulated by connective tissue. They are found in the dermis and subcutaneous tissue of the skin, particularly in the fingertips and joints. They respond to sustained pressure and tangential force, making them important for the perception of object slippage and texture.
The bulbous corpuscle is a type of slowly adapting mechanoreceptor, meaning it continues to fire action potentials as long as the mechanical stimulus continues. They are also thermoreceptors, sensitive to temperature changes, particularly warmth.
Clinical Significance[edit | edit source]
Damage or disease affecting the bulbous corpuscles can lead to a loss of pressure and skin distortion sensation, affecting a person's ability to perceive their environment and handle objects. Conditions such as diabetes and leprosy can damage these receptors, leading to a loss of sensation in the affected areas.
Related Terms[edit | edit source]
- Mechanoreceptor: A sensory receptor that responds to mechanical pressure or distortion.
- Dermis: The layer of skin between the epidermis and subcutaneous tissues.
- Subcutaneous tissue: The layer of tissue beneath the skin, consisting mainly of fat and connective tissue.
- Angelo Ruffini: An Italian histologist who first described the Ruffini endings.
See Also[edit | edit source]
Bulbous corpuscle Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD